While Cellex Inc. is the only company to receive EUA* for a serological test against COVID-19, 90 test developers have taken advantage of the opportunity to launch COVID-19 serological assays without any agency review.
…Cellex’s FDA-authorized test has a sensitivity of 93.8% and a specificity is 95.6%; it was tested at two Chinese hospitals in a total of 128 and 250 patients that tested positive and negative for COVID-19 via RT-PCR, respectively.
*Emergency Use Authorization.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”